The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer

被引:161
作者
Park, J. H. [1 ]
Richards, C. H. [1 ]
McMillan, D. C. [1 ]
Horgan, P. G. [1 ]
Roxburgh, C. S. D. [1 ]
机构
[1] Univ Glasgow, Glasgow Royal Infirm, Acad Surg Unit, Sch Med, Glasgow G31 2ER, Lanark, Scotland
关键词
tumour stroma; tumour microenvironment; colorectal cancer; survival; INFLAMMATORY RESPONSES; COLON-CANCER; FIBROBLASTS; VALIDATION; RECURRENCE; EXPRESSION; CARCINOMA; NECROSIS; DISEASE; CELLS;
D O I
10.1093/annonc/mdt593
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumour microenvironment, particularly the tumour stroma, has a key role in cancer progression and survival. In the present study, a high tumour stroma percentage (TSP) is identified as a marker of poor prognosis in colorectal cancer, independent of other host and tumour determinants of survival. Furthermore, associations between TSP and clinicopathological characteristics suggest a pertinent role in facilitating tumour growth and invasion.Tumour stroma percentage (TSP) has previously been reported to predict survival in patients with colorectal cancer (CRC); however, whether this is independent of other aspects of the tumour microenvironment is unknown. In the present study, the relationship between TSP, the tumour microenvironment and survival was examined in patients undergoing elective, curative CRC resection. Patients undergoing resection at a single centre (1997-2008) were identified from a prospective database. TSP was measured at the invasive margin and its association with cancer-specific survival (CSS) and clinicopathological characteristics examined. Three hundred and thirty-one patients were included in the analysis. TSP was associated with CSS in patients with stage I-III disease [hazard ratio (HR) 1.84, 95% confidence interval (CI) 1.17-2.92, P = 0.009], independent of age, systemic inflammation, N stage, venous invasion and Klintrup-Makinen score. Furthermore, TSP was associated with reduced CSS in patients with node-negative disease (HR 2.14, 95% CI 1.01-4.54, P = 0.048) and those who received adjuvant chemotherapy (HR 2.83, 95% CI 1.23-6.53, P = 0.015), independent of venous invasion and host inflammatory responses. TSP was associated with several adverse pathological characteristics, including advanced T and N stage. Furthermore, TSP was associated with an infiltrative invasive margin and inversely associated with necrosis. The TSP was a significant predictor of survival in patients undergoing elective, curative CRC resection, independent of adverse pathological characteristics and host inflammatory responses. In addition, TSP was strongly associated with local tumour growth and invasion.
引用
收藏
页码:644 / 651
页数:8
相关论文
共 30 条
  • [1] [Anonymous], 1997, AJCC CANC STAGING MA
  • [2] Role of tissue stroma in cancer cell invasion
    De Wever, O
    Mareel, M
    [J]. JOURNAL OF PATHOLOGY, 2003, 200 (04) : 429 - 447
  • [3] Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
    Dekker, T. J. A.
    van de Velde, C. J. H.
    van Pelt, G. W.
    Kroep, J. R.
    Julien, J-P.
    Smit, V. T. H. B. M.
    Tollenaar, R. A. E. M.
    Mesker, W. E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 371 - 379
  • [4] Targeting stroma to treat cancers
    Engels, Boris
    Rowley, Donald A.
    Schreiber, Hans
    [J]. SEMINARS IN CANCER BIOLOGY, 2012, 22 (01) : 41 - 49
  • [5] Can Stroma Reaction Predict Cancer Lethality?
    Freeman, Michael R.
    Li, Quanlin
    Chung, Leland W. K.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (18) : 4905 - 4907
  • [6] Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
    Fridman, Wolf Herman
    Galon, Jerome
    Pages, Franck
    Tartour, Eric
    Sautes-Fridman, Catherine
    Kroemer, Guido
    [J]. CANCER RESEARCH, 2011, 71 (17) : 5601 - 5605
  • [7] Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer
    Guthrie, G. J. K.
    Roxburgh, C. S. D.
    Richards, C. H.
    Horgan, P. G.
    McMillan, D. C.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 109 (01) : 131 - 137
  • [8] Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis
    Hemmings, Chris
    [J]. PATHOLOGY, 2013, 45 (04) : 371 - 381
  • [9] Surgeons and selection of adjuvant therapy for node-negative colonic cancer
    Horgan, P. G.
    McMillan, D. C.
    [J]. BRITISH JOURNAL OF SURGERY, 2010, 97 (10) : 1459 - 1460
  • [10] The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial
    Huijbers, A.
    Tollenaar, R. A. E. M.
    v Pelt, G. W.
    Zeestraten, E. C. M.
    Dutton, S.
    McConkey, C. C.
    Domingo, E.
    Smit, V. T. H. B. M.
    Midgley, R.
    Warren, B. F.
    Johnstone, E. C.
    Kerr, D. J.
    Mesker, W. E.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (01) : 179 - 185